Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of UPJO

This study has been terminated.
Sponsor:
Collaborators:
Division of Urology, St. Joseph's Hospital, St. Joseph's Health Care London
General Electric
Information provided by:
Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT00199472
First received: September 13, 2005
Last updated: June 19, 2006
Last verified: June 2006
  Purpose

Renal blood flow is inversely related to obstruction. We propose that this imaging will be as effective as the diuretic renogram in the functional diagnosis of obstruction. Furthermore, dynamic contrast CT scanning may also add anatomic information necessary for the surgical treatment.


Condition Intervention
Ureteral Obstruction
Procedure: Dynamic Contrast Enhanced CT & Diuretic Renogram

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Official Title: Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of Ureteropelvic Junction Obstruction

Further study details as provided by Lawson Health Research Institute:

Estimated Enrollment: 10
Study Start Date: April 2001
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years of age or older;
  • Subjects suspected to have UPJO.

Exclusion Criteria:

  • Pregnancy;
  • Renal failure (Creatinine >150);
  • Allergy to contrast material;
  • Ureteral stent;
  • Nephrostomy tube;
  • Renal pelvis calculi.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00199472

Locations
Canada, Ontario
Urology Clinic, St. Joseph's Hospital, St. Joseph's Health Care London
London, Ontario, Canada, N6A 4V2
Sponsors and Collaborators
Lawson Health Research Institute
Division of Urology, St. Joseph's Hospital, St. Joseph's Health Care London
General Electric
Investigators
Principal Investigator: John D Denstedt, MD, FRCSC Urology, St. Joseph's Hospital, University of Western Ontario
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00199472     History of Changes
Other Study ID Numbers: 07378
Study First Received: September 13, 2005
Last Updated: June 19, 2006
Health Authority: Canada: Health Canada

Additional relevant MeSH terms:
Ureteral Obstruction
Ureteral Diseases
Urologic Diseases
Diuretics
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on November 20, 2014